CSF chromogranin A-like immunoreactivity in schizophrenia: relationships with REM latency and slow wave sleep

Psychiatry Res. 1992 Apr;42(1):53-63. doi: 10.1016/0165-1781(92)90038-5.

Abstract

Chromogranin A (CgA) is a calcium binding protein and a precursor of modulatory peptides in the brain. We measured CgA-like immunoreactivity (CgA-LI) in cerebrospinal fluid (CSF) in 15 male schizophrenic patients (diagnosed by DSM-III-R criteria) after 3 nights of polysomnography. Patients had been drug free for at least 33 days. Our earlier report that CSF CgA-LI in schizophrenic patients correlated significantly with negative symptoms and ventricle-brain ratios, which have been related to slow wave sleep, raised the possibility that CgA-LI might relate to slow wave sleep. CSF CgA-LI was significantly correlated with stage 4 sleep and rapid eye movement latency. Whether these positive relationships between CSF CgA-LI and electroencephalographic sleep measures are specific for schizophrenia awaits further study.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Chromogranin A
  • Chromogranins / cerebrospinal fluid*
  • Electroencephalography*
  • Humans
  • Male
  • Radioimmunoassay
  • Reaction Time / physiology*
  • Schizophrenia / cerebrospinal fluid*
  • Schizophrenic Psychology*
  • Sleep Stages / physiology*
  • Sleep, REM / physiology*

Substances

  • CHGA protein, human
  • Chromogranin A
  • Chromogranins